nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ABCB1—colon cancer	0.255	1	CbGaD
Losartan—UGT1A1—Irinotecan—colon cancer	0.0818	0.162	CbGbCtD
Losartan—SLCO1B1—Irinotecan—colon cancer	0.0566	0.112	CbGbCtD
Losartan—SLCO1B3—Methotrexate—colon cancer	0.0515	0.102	CbGbCtD
Losartan—ALB—Irinotecan—colon cancer	0.031	0.0615	CbGbCtD
Losartan—SLCO1B1—Methotrexate—colon cancer	0.03	0.0594	CbGbCtD
Losartan—ALB—Fluorouracil—colon cancer	0.0298	0.059	CbGbCtD
Losartan—CYP2C9—Capecitabine—colon cancer	0.0271	0.0537	CbGbCtD
Losartan—CYP3A5—Irinotecan—colon cancer	0.0249	0.0494	CbGbCtD
Losartan—CYP2C8—Fluorouracil—colon cancer	0.023	0.0456	CbGbCtD
Losartan—CYP3A5—Vincristine—colon cancer	0.0218	0.0432	CbGbCtD
Losartan—SLC22A6—Methotrexate—colon cancer	0.0193	0.0382	CbGbCtD
Losartan—CYP1A2—Fluorouracil—colon cancer	0.0178	0.0353	CbGbCtD
Losartan—ALB—Methotrexate—colon cancer	0.0164	0.0326	CbGbCtD
Losartan—ABCB1—Irinotecan—colon cancer	0.0162	0.0322	CbGbCtD
Losartan—CYP2C9—Fluorouracil—colon cancer	0.016	0.0318	CbGbCtD
Losartan—ABCB1—Vincristine—colon cancer	0.0142	0.0281	CbGbCtD
Losartan—CYP3A4—Irinotecan—colon cancer	0.00972	0.0193	CbGbCtD
Losartan—ABCB1—Methotrexate—colon cancer	0.00859	0.017	CbGbCtD
Losartan—CYP3A4—Vincristine—colon cancer	0.0085	0.0169	CbGbCtD
Losartan—UGT2B17—epithelium—colon cancer	0.00633	0.0709	CbGeAlD
Losartan—ACE—vein—colon cancer	0.00513	0.0575	CbGeAlD
Losartan—UGT2B17—digestive system—colon cancer	0.00481	0.0539	CbGeAlD
Losartan—SLC22A12—renal system—colon cancer	0.00378	0.0424	CbGeAlD
Losartan—ACE—umbilical vein—colon cancer	0.00373	0.0417	CbGeAlD
Losartan—UGT2B17—liver—colon cancer	0.00359	0.0402	CbGeAlD
Losartan—UGT1A10—renal system—colon cancer	0.00332	0.0372	CbGeAlD
Losartan—SLC22A12—digestive system—colon cancer	0.0031	0.0348	CbGeAlD
Losartan—UGT1A10—digestive system—colon cancer	0.00272	0.0305	CbGeAlD
Losartan—SLC2A9—renal system—colon cancer	0.0026	0.0291	CbGeAlD
Losartan—AGTR1—endothelium—colon cancer	0.00239	0.0268	CbGeAlD
Losartan—AGTR1—blood vessel—colon cancer	0.00221	0.0247	CbGeAlD
Losartan—UGT1A10—liver—colon cancer	0.00203	0.0227	CbGeAlD
Losartan—UGT1A3—digestive system—colon cancer	0.00192	0.0215	CbGeAlD
Losartan—ACE—endothelium—colon cancer	0.00177	0.0198	CbGeAlD
Losartan—Telmisartan—PPARG—colon cancer	0.00175	0.607	CrCbGaD
Losartan—ACE—blood vessel—colon cancer	0.00163	0.0182	CbGeAlD
Losartan—ALB—gall bladder—colon cancer	0.0016	0.0179	CbGeAlD
Losartan—SLC2A9—liver—colon cancer	0.00159	0.0178	CbGeAlD
Losartan—UGT1A3—liver—colon cancer	0.00143	0.016	CbGeAlD
Losartan—UGT2B7—renal system—colon cancer	0.00134	0.015	CbGeAlD
Losartan—SLC2A9—lymph node—colon cancer	0.00122	0.0136	CbGeAlD
Losartan—SLCO1B3—vagina—colon cancer	0.00119	0.0133	CbGeAlD
Losartan—UGT1A1—renal system—colon cancer	0.00114	0.0128	CbGeAlD
Losartan—UGT2B7—digestive system—colon cancer	0.0011	0.0123	CbGeAlD
Losartan—AGTR1—epithelium—colon cancer	0.00107	0.012	CbGeAlD
Losartan—AGTR1—smooth muscle tissue—colon cancer	0.00103	0.0116	CbGeAlD
Losartan—SLCO1B3—liver—colon cancer	0.001	0.0112	CbGeAlD
Losartan—AGTR1—renal system—colon cancer	0.000996	0.0112	CbGeAlD
Losartan—ACE—embryo—colon cancer	0.000971	0.0109	CbGeAlD
Losartan—SLCO1B1—renal system—colon cancer	0.000949	0.0106	CbGeAlD
Losartan—UGT1A1—digestive system—colon cancer	0.000936	0.0105	CbGeAlD
Losartan—AGTR1—lymphoid tissue—colon cancer	0.000827	0.00926	CbGeAlD
Losartan—UGT2B7—liver—colon cancer	0.00082	0.00919	CbGeAlD
Losartan—ACE—epithelium—colon cancer	0.000793	0.00888	CbGeAlD
Losartan—SLCO1B1—digestive system—colon cancer	0.000779	0.00872	CbGeAlD
Losartan—ACE—smooth muscle tissue—colon cancer	0.000764	0.00856	CbGeAlD
Losartan—ACE—renal system—colon cancer	0.000735	0.00824	CbGeAlD
Losartan—AGTR1—vagina—colon cancer	0.000721	0.00808	CbGeAlD
Losartan—UGT1A1—liver—colon cancer	0.000697	0.00781	CbGeAlD
Losartan—Telmisartan—ABCB1—colon cancer	0.000628	0.218	CrCbGaD
Losartan—ACE—lymphoid tissue—colon cancer	0.000611	0.00684	CbGeAlD
Losartan—AGTR1—liver—colon cancer	0.000608	0.00682	CbGeAlD
Losartan—ACE—digestive system—colon cancer	0.000603	0.00676	CbGeAlD
Losartan—SLCO1B1—liver—colon cancer	0.00058	0.0065	CbGeAlD
Losartan—ABCB1—blood vessel—colon cancer	0.000573	0.00642	CbGeAlD
Losartan—ACE—bone marrow—colon cancer	0.000556	0.00623	CbGeAlD
Losartan—CYP2C8—renal system—colon cancer	0.00054	0.00605	CbGeAlD
Losartan—CYP2C19—digestive system—colon cancer	0.000507	0.00568	CbGeAlD
Losartan—Candesartan—ABCB1—colon cancer	0.000506	0.176	CrCbGaD
Losartan—CYP1A2—renal system—colon cancer	0.000505	0.00566	CbGeAlD
Losartan—CYP3A5—renal system—colon cancer	0.000487	0.00546	CbGeAlD
Losartan—ALB—liver—colon cancer	0.000469	0.00526	CbGeAlD
Losartan—AGTR1—lymph node—colon cancer	0.000467	0.00523	CbGeAlD
Losartan—ACE—liver—colon cancer	0.000449	0.00503	CbGeAlD
Losartan—CYP2C19—vagina—colon cancer	0.000448	0.00502	CbGeAlD
Losartan—CYP1A2—digestive system—colon cancer	0.000414	0.00464	CbGeAlD
Losartan—CYP3A5—digestive system—colon cancer	0.0004	0.00448	CbGeAlD
Losartan—CYP2C9—digestive system—colon cancer	0.000393	0.00441	CbGeAlD
Losartan—CYP2C8—vagina—colon cancer	0.000391	0.00438	CbGeAlD
Losartan—CYP2C19—liver—colon cancer	0.000378	0.00423	CbGeAlD
Losartan—CYP3A4—renal system—colon cancer	0.000366	0.0041	CbGeAlD
Losartan—ALB—lymph node—colon cancer	0.00036	0.00403	CbGeAlD
Losartan—CYP3A5—vagina—colon cancer	0.000353	0.00395	CbGeAlD
Losartan—ACE—lymph node—colon cancer	0.000344	0.00386	CbGeAlD
Losartan—ABCB1—embryo—colon cancer	0.000342	0.00383	CbGeAlD
Losartan—CYP2C8—liver—colon cancer	0.00033	0.0037	CbGeAlD
Losartan—CYP1A2—liver—colon cancer	0.000309	0.00346	CbGeAlD
Losartan—CYP3A4—digestive system—colon cancer	0.0003	0.00336	CbGeAlD
Losartan—Leukopenia—Vincristine—colon cancer	0.000299	0.00278	CcSEcCtD
Losartan—CYP3A5—liver—colon cancer	0.000298	0.00334	CbGeAlD
Losartan—Vision blurred—Fluorouracil—colon cancer	0.000294	0.00273	CcSEcCtD
Losartan—Malaise—Irinotecan—colon cancer	0.000293	0.00273	CcSEcCtD
Losartan—CYP2C9—liver—colon cancer	0.000293	0.00328	CbGeAlD
Losartan—Vertigo—Irinotecan—colon cancer	0.000292	0.00272	CcSEcCtD
Losartan—Syncope—Irinotecan—colon cancer	0.000292	0.00271	CcSEcCtD
Losartan—Leukopenia—Irinotecan—colon cancer	0.000291	0.00271	CcSEcCtD
Losartan—Upper respiratory tract infection—Capecitabine—colon cancer	0.00029	0.0027	CcSEcCtD
Losartan—Anaemia—Fluorouracil—colon cancer	0.000288	0.00268	CcSEcCtD
Losartan—Loss of consciousness—Irinotecan—colon cancer	0.000286	0.00266	CcSEcCtD
Losartan—Dermatitis exfoliative—Methotrexate—colon cancer	0.000285	0.00265	CcSEcCtD
Losartan—Photosensitivity reaction—Capecitabine—colon cancer	0.000285	0.00265	CcSEcCtD
Losartan—Myalgia—Vincristine—colon cancer	0.000284	0.00264	CcSEcCtD
Losartan—Weight increased—Capecitabine—colon cancer	0.000284	0.00264	CcSEcCtD
Losartan—Cough—Irinotecan—colon cancer	0.000284	0.00264	CcSEcCtD
Losartan—Hyperglycaemia—Capecitabine—colon cancer	0.000282	0.00262	CcSEcCtD
Losartan—Pneumonia—Capecitabine—colon cancer	0.00028	0.0026	CcSEcCtD
Losartan—ABCB1—epithelium—colon cancer	0.000279	0.00313	CbGeAlD
Losartan—Leukopenia—Fluorouracil—colon cancer	0.000279	0.00259	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000276	0.00257	CcSEcCtD
Losartan—Renal failure—Capecitabine—colon cancer	0.000274	0.00255	CcSEcCtD
Losartan—Discomfort—Irinotecan—colon cancer	0.000274	0.00254	CcSEcCtD
Losartan—Neuropathy peripheral—Capecitabine—colon cancer	0.000273	0.00254	CcSEcCtD
Losartan—Oedema—Vincristine—colon cancer	0.000273	0.00253	CcSEcCtD
Losartan—Anaphylactic shock—Vincristine—colon cancer	0.000273	0.00253	CcSEcCtD
Losartan—Jaundice—Capecitabine—colon cancer	0.000272	0.00252	CcSEcCtD
Losartan—Infection—Vincristine—colon cancer	0.000271	0.00252	CcSEcCtD
Losartan—Conjunctivitis—Capecitabine—colon cancer	0.000271	0.00252	CcSEcCtD
Losartan—Urinary tract infection—Capecitabine—colon cancer	0.000271	0.00252	CcSEcCtD
Losartan—Confusional state—Irinotecan—colon cancer	0.000268	0.00249	CcSEcCtD
Losartan—Nervous system disorder—Vincristine—colon cancer	0.000267	0.00249	CcSEcCtD
Losartan—Thrombocytopenia—Vincristine—colon cancer	0.000267	0.00248	CcSEcCtD
Losartan—Anaphylactic shock—Irinotecan—colon cancer	0.000266	0.00247	CcSEcCtD
Losartan—Oedema—Irinotecan—colon cancer	0.000266	0.00247	CcSEcCtD
Losartan—Chest pain—Fluorouracil—colon cancer	0.000265	0.00247	CcSEcCtD
Losartan—Myalgia—Fluorouracil—colon cancer	0.000265	0.00247	CcSEcCtD
Losartan—Infection—Irinotecan—colon cancer	0.000264	0.00245	CcSEcCtD
Losartan—Hyperhidrosis—Vincristine—colon cancer	0.000264	0.00245	CcSEcCtD
Losartan—Epistaxis—Capecitabine—colon cancer	0.000263	0.00244	CcSEcCtD
Losartan—Discomfort—Fluorouracil—colon cancer	0.000262	0.00244	CcSEcCtD
Losartan—Shock—Irinotecan—colon cancer	0.000261	0.00243	CcSEcCtD
Losartan—Nervous system disorder—Irinotecan—colon cancer	0.00026	0.00242	CcSEcCtD
Losartan—Agranulocytosis—Capecitabine—colon cancer	0.00026	0.00242	CcSEcCtD
Losartan—Thrombocytopenia—Irinotecan—colon cancer	0.00026	0.00242	CcSEcCtD
Losartan—Anorexia—Vincristine—colon cancer	0.00026	0.00242	CcSEcCtD
Losartan—ABCB1—renal system—colon cancer	0.000259	0.0029	CbGeAlD
Losartan—Hyperhidrosis—Irinotecan—colon cancer	0.000257	0.00239	CcSEcCtD
Losartan—Confusional state—Fluorouracil—colon cancer	0.000256	0.00238	CcSEcCtD
Losartan—Hypotension—Vincristine—colon cancer	0.000255	0.00237	CcSEcCtD
Losartan—Anaphylactic shock—Fluorouracil—colon cancer	0.000254	0.00236	CcSEcCtD
Losartan—Oedema—Fluorouracil—colon cancer	0.000254	0.00236	CcSEcCtD
Losartan—Anorexia—Irinotecan—colon cancer	0.000253	0.00235	CcSEcCtD
Losartan—Ataxia—Methotrexate—colon cancer	0.000253	0.00235	CcSEcCtD
Losartan—Infection—Fluorouracil—colon cancer	0.000253	0.00235	CcSEcCtD
Losartan—Rhinitis—Capecitabine—colon cancer	0.000251	0.00233	CcSEcCtD
Losartan—Hepatitis—Capecitabine—colon cancer	0.00025	0.00233	CcSEcCtD
Losartan—Nervous system disorder—Fluorouracil—colon cancer	0.000249	0.00232	CcSEcCtD
Losartan—Thrombocytopenia—Fluorouracil—colon cancer	0.000249	0.00231	CcSEcCtD
Losartan—Hypoaesthesia—Capecitabine—colon cancer	0.000249	0.00231	CcSEcCtD
Losartan—Musculoskeletal discomfort—Vincristine—colon cancer	0.000248	0.00231	CcSEcCtD
Losartan—Pharyngitis—Capecitabine—colon cancer	0.000248	0.00231	CcSEcCtD
Losartan—Tachycardia—Fluorouracil—colon cancer	0.000248	0.00231	CcSEcCtD
Losartan—Hypotension—Irinotecan—colon cancer	0.000248	0.00231	CcSEcCtD
Losartan—Insomnia—Vincristine—colon cancer	0.000247	0.00229	CcSEcCtD
Losartan—Paraesthesia—Vincristine—colon cancer	0.000245	0.00228	CcSEcCtD
Losartan—Breast disorder—Methotrexate—colon cancer	0.000243	0.00226	CcSEcCtD
Losartan—Anorexia—Fluorouracil—colon cancer	0.000242	0.00225	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000242	0.00225	CcSEcCtD
Losartan—Insomnia—Irinotecan—colon cancer	0.00024	0.00223	CcSEcCtD
Losartan—Paraesthesia—Irinotecan—colon cancer	0.000238	0.00222	CcSEcCtD
Losartan—Hypotension—Fluorouracil—colon cancer	0.000238	0.00221	CcSEcCtD
Losartan—Decreased appetite—Vincristine—colon cancer	0.000237	0.0022	CcSEcCtD
Losartan—Dyspnoea—Irinotecan—colon cancer	0.000237	0.0022	CcSEcCtD
Losartan—Erythema multiforme—Capecitabine—colon cancer	0.000237	0.0022	CcSEcCtD
Losartan—Somnolence—Irinotecan—colon cancer	0.000236	0.00219	CcSEcCtD
Losartan—Fatigue—Vincristine—colon cancer	0.000235	0.00218	CcSEcCtD
Losartan—Dyspepsia—Irinotecan—colon cancer	0.000234	0.00217	CcSEcCtD
Losartan—Tinnitus—Capecitabine—colon cancer	0.000233	0.00217	CcSEcCtD
Losartan—Pain—Vincristine—colon cancer	0.000233	0.00217	CcSEcCtD
Losartan—Constipation—Vincristine—colon cancer	0.000233	0.00217	CcSEcCtD
Losartan—Flushing—Capecitabine—colon cancer	0.000232	0.00216	CcSEcCtD
Losartan—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000232	0.00215	CcSEcCtD
Losartan—Decreased appetite—Irinotecan—colon cancer	0.000231	0.00215	CcSEcCtD
Losartan—Eosinophilia—Methotrexate—colon cancer	0.00023	0.00214	CcSEcCtD
Losartan—Insomnia—Fluorouracil—colon cancer	0.00023	0.00214	CcSEcCtD
Losartan—Fatigue—Irinotecan—colon cancer	0.000229	0.00213	CcSEcCtD
Losartan—Paraesthesia—Fluorouracil—colon cancer	0.000228	0.00212	CcSEcCtD
Losartan—Pancreatitis—Methotrexate—colon cancer	0.000228	0.00212	CcSEcCtD
Losartan—Pain—Irinotecan—colon cancer	0.000227	0.00211	CcSEcCtD
Losartan—Constipation—Irinotecan—colon cancer	0.000227	0.00211	CcSEcCtD
Losartan—Angiopathy—Capecitabine—colon cancer	0.000227	0.00211	CcSEcCtD
Losartan—Dyspnoea—Fluorouracil—colon cancer	0.000227	0.00211	CcSEcCtD
Losartan—Somnolence—Fluorouracil—colon cancer	0.000226	0.0021	CcSEcCtD
Losartan—Dyspepsia—Fluorouracil—colon cancer	0.000224	0.00208	CcSEcCtD
Losartan—Arrhythmia—Capecitabine—colon cancer	0.000223	0.00208	CcSEcCtD
Losartan—CYP3A4—liver—colon cancer	0.000223	0.0025	CbGeAlD
Losartan—Gastrointestinal pain—Vincristine—colon cancer	0.000223	0.00207	CcSEcCtD
Losartan—Decreased appetite—Fluorouracil—colon cancer	0.000221	0.00205	CcSEcCtD
Losartan—Alopecia—Capecitabine—colon cancer	0.000221	0.00205	CcSEcCtD
Losartan—Feeling abnormal—Irinotecan—colon cancer	0.000219	0.00203	CcSEcCtD
Losartan—Erythema—Capecitabine—colon cancer	0.000218	0.00202	CcSEcCtD
Losartan—Pain—Fluorouracil—colon cancer	0.000217	0.00202	CcSEcCtD
Losartan—Gastrointestinal pain—Irinotecan—colon cancer	0.000217	0.00202	CcSEcCtD
Losartan—Upper respiratory tract infection—Methotrexate—colon cancer	0.000216	0.00201	CcSEcCtD
Losartan—Body temperature increased—Vincristine—colon cancer	0.000216	0.002	CcSEcCtD
Losartan—Abdominal pain—Vincristine—colon cancer	0.000216	0.002	CcSEcCtD
Losartan—ABCB1—lymphoid tissue—colon cancer	0.000215	0.00241	CbGeAlD
Losartan—Flatulence—Capecitabine—colon cancer	0.000215	0.00199	CcSEcCtD
Losartan—Erectile dysfunction—Methotrexate—colon cancer	0.000214	0.00199	CcSEcCtD
Losartan—Dysgeusia—Capecitabine—colon cancer	0.000213	0.00198	CcSEcCtD
Losartan—Photosensitivity reaction—Methotrexate—colon cancer	0.000212	0.00197	CcSEcCtD
Losartan—ABCB1—digestive system—colon cancer	0.000212	0.00238	CbGeAlD
Losartan—Back pain—Capecitabine—colon cancer	0.000211	0.00196	CcSEcCtD
Losartan—Abdominal pain—Irinotecan—colon cancer	0.00021	0.00195	CcSEcCtD
Losartan—Body temperature increased—Irinotecan—colon cancer	0.00021	0.00195	CcSEcCtD
Losartan—Feeling abnormal—Fluorouracil—colon cancer	0.00021	0.00195	CcSEcCtD
Losartan—Muscle spasms—Capecitabine—colon cancer	0.000209	0.00195	CcSEcCtD
Losartan—Pneumonia—Methotrexate—colon cancer	0.000209	0.00194	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000206	0.00191	CcSEcCtD
Losartan—Vision blurred—Capecitabine—colon cancer	0.000205	0.00191	CcSEcCtD
Losartan—Tremor—Capecitabine—colon cancer	0.000204	0.0019	CcSEcCtD
Losartan—Renal failure—Methotrexate—colon cancer	0.000204	0.0019	CcSEcCtD
Losartan—Ill-defined disorder—Capecitabine—colon cancer	0.000202	0.00188	CcSEcCtD
Losartan—Urticaria—Fluorouracil—colon cancer	0.000202	0.00188	CcSEcCtD
Losartan—Conjunctivitis—Methotrexate—colon cancer	0.000202	0.00187	CcSEcCtD
Losartan—Anaemia—Capecitabine—colon cancer	0.000201	0.00187	CcSEcCtD
Losartan—Body temperature increased—Fluorouracil—colon cancer	0.000201	0.00187	CcSEcCtD
Losartan—Hypersensitivity—Vincristine—colon cancer	0.000201	0.00187	CcSEcCtD
Losartan—Sweating—Methotrexate—colon cancer	0.000199	0.00185	CcSEcCtD
Losartan—Malaise—Capecitabine—colon cancer	0.000196	0.00183	CcSEcCtD
Losartan—ABCB1—bone marrow—colon cancer	0.000196	0.00219	CbGeAlD
Losartan—Epistaxis—Methotrexate—colon cancer	0.000196	0.00182	CcSEcCtD
Losartan—Vertigo—Capecitabine—colon cancer	0.000196	0.00182	CcSEcCtD
Losartan—Hypersensitivity—Irinotecan—colon cancer	0.000196	0.00182	CcSEcCtD
Losartan—Asthenia—Vincristine—colon cancer	0.000196	0.00182	CcSEcCtD
Losartan—Syncope—Capecitabine—colon cancer	0.000195	0.00182	CcSEcCtD
Losartan—Leukopenia—Capecitabine—colon cancer	0.000195	0.00181	CcSEcCtD
Losartan—Agranulocytosis—Methotrexate—colon cancer	0.000194	0.0018	CcSEcCtD
Losartan—Palpitations—Capecitabine—colon cancer	0.000192	0.00179	CcSEcCtD
Losartan—Loss of consciousness—Capecitabine—colon cancer	0.000191	0.00178	CcSEcCtD
Losartan—Asthenia—Irinotecan—colon cancer	0.000191	0.00177	CcSEcCtD
Losartan—Cough—Capecitabine—colon cancer	0.00019	0.00177	CcSEcCtD
Losartan—ABCB1—vagina—colon cancer	0.000187	0.0021	CbGeAlD
Losartan—Hypersensitivity—Fluorouracil—colon cancer	0.000187	0.00174	CcSEcCtD
Losartan—Diarrhoea—Vincristine—colon cancer	0.000187	0.00173	CcSEcCtD
Losartan—Hepatitis—Methotrexate—colon cancer	0.000186	0.00173	CcSEcCtD
Losartan—Arthralgia—Capecitabine—colon cancer	0.000185	0.00172	CcSEcCtD
Losartan—Myalgia—Capecitabine—colon cancer	0.000185	0.00172	CcSEcCtD
Losartan—Chest pain—Capecitabine—colon cancer	0.000185	0.00172	CcSEcCtD
Losartan—Pharyngitis—Methotrexate—colon cancer	0.000185	0.00172	CcSEcCtD
Losartan—Anxiety—Capecitabine—colon cancer	0.000185	0.00172	CcSEcCtD
Losartan—Discomfort—Capecitabine—colon cancer	0.000183	0.0017	CcSEcCtD
Losartan—Diarrhoea—Irinotecan—colon cancer	0.000182	0.00169	CcSEcCtD
Losartan—Dry mouth—Capecitabine—colon cancer	0.000181	0.00169	CcSEcCtD
Losartan—Dizziness—Vincristine—colon cancer	0.00018	0.00168	CcSEcCtD
Losartan—Pruritus—Fluorouracil—colon cancer	0.00018	0.00167	CcSEcCtD
Losartan—Confusional state—Capecitabine—colon cancer	0.000179	0.00167	CcSEcCtD
Losartan—Oedema—Capecitabine—colon cancer	0.000178	0.00165	CcSEcCtD
Losartan—Infection—Capecitabine—colon cancer	0.000177	0.00164	CcSEcCtD
Losartan—Erythema multiforme—Methotrexate—colon cancer	0.000176	0.00164	CcSEcCtD
Losartan—Dizziness—Irinotecan—colon cancer	0.000176	0.00163	CcSEcCtD
Losartan—Shock—Capecitabine—colon cancer	0.000175	0.00163	CcSEcCtD
Losartan—Nervous system disorder—Capecitabine—colon cancer	0.000174	0.00162	CcSEcCtD
Losartan—Diarrhoea—Fluorouracil—colon cancer	0.000174	0.00162	CcSEcCtD
Losartan—Thrombocytopenia—Capecitabine—colon cancer	0.000174	0.00162	CcSEcCtD
Losartan—Tinnitus—Methotrexate—colon cancer	0.000174	0.00161	CcSEcCtD
Losartan—Tachycardia—Capecitabine—colon cancer	0.000173	0.00161	CcSEcCtD
Losartan—Vomiting—Vincristine—colon cancer	0.000173	0.00161	CcSEcCtD
Losartan—Rash—Vincristine—colon cancer	0.000172	0.0016	CcSEcCtD
Losartan—Hyperhidrosis—Capecitabine—colon cancer	0.000172	0.0016	CcSEcCtD
Losartan—Dermatitis—Vincristine—colon cancer	0.000172	0.0016	CcSEcCtD
Losartan—Headache—Vincristine—colon cancer	0.000171	0.00159	CcSEcCtD
Losartan—Anorexia—Capecitabine—colon cancer	0.000169	0.00157	CcSEcCtD
Losartan—Angiopathy—Methotrexate—colon cancer	0.000169	0.00157	CcSEcCtD
Losartan—Vomiting—Irinotecan—colon cancer	0.000169	0.00157	CcSEcCtD
Losartan—Dizziness—Fluorouracil—colon cancer	0.000168	0.00156	CcSEcCtD
Losartan—Rash—Irinotecan—colon cancer	0.000167	0.00156	CcSEcCtD
Losartan—Dermatitis—Irinotecan—colon cancer	0.000167	0.00155	CcSEcCtD
Losartan—Headache—Irinotecan—colon cancer	0.000166	0.00155	CcSEcCtD
Losartan—Hypotension—Capecitabine—colon cancer	0.000166	0.00154	CcSEcCtD
Losartan—Alopecia—Methotrexate—colon cancer	0.000165	0.00153	CcSEcCtD
Losartan—Erythema—Methotrexate—colon cancer	0.000162	0.00151	CcSEcCtD
Losartan—Nausea—Vincristine—colon cancer	0.000162	0.00151	CcSEcCtD
Losartan—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000162	0.0015	CcSEcCtD
Losartan—Vomiting—Fluorouracil—colon cancer	0.000162	0.0015	CcSEcCtD
Losartan—Insomnia—Capecitabine—colon cancer	0.000161	0.00149	CcSEcCtD
Losartan—Rash—Fluorouracil—colon cancer	0.00016	0.00149	CcSEcCtD
Losartan—Dermatitis—Fluorouracil—colon cancer	0.00016	0.00149	CcSEcCtD
Losartan—Paraesthesia—Capecitabine—colon cancer	0.00016	0.00148	CcSEcCtD
Losartan—Headache—Fluorouracil—colon cancer	0.000159	0.00148	CcSEcCtD
Losartan—Dysgeusia—Methotrexate—colon cancer	0.000159	0.00148	CcSEcCtD
Losartan—Dyspnoea—Capecitabine—colon cancer	0.000158	0.00147	CcSEcCtD
Losartan—ABCB1—liver—colon cancer	0.000158	0.00177	CbGeAlD
Losartan—Nausea—Irinotecan—colon cancer	0.000158	0.00147	CcSEcCtD
Losartan—Back pain—Methotrexate—colon cancer	0.000157	0.00146	CcSEcCtD
Losartan—Dyspepsia—Capecitabine—colon cancer	0.000156	0.00145	CcSEcCtD
Losartan—Decreased appetite—Capecitabine—colon cancer	0.000154	0.00144	CcSEcCtD
Losartan—Fatigue—Capecitabine—colon cancer	0.000153	0.00142	CcSEcCtD
Losartan—Vision blurred—Methotrexate—colon cancer	0.000153	0.00142	CcSEcCtD
Losartan—Pain—Capecitabine—colon cancer	0.000152	0.00141	CcSEcCtD
Losartan—Constipation—Capecitabine—colon cancer	0.000152	0.00141	CcSEcCtD
Losartan—Nausea—Fluorouracil—colon cancer	0.000151	0.0014	CcSEcCtD
Losartan—Ill-defined disorder—Methotrexate—colon cancer	0.00015	0.0014	CcSEcCtD
Losartan—Anaemia—Methotrexate—colon cancer	0.00015	0.00139	CcSEcCtD
Losartan—Feeling abnormal—Capecitabine—colon cancer	0.000146	0.00136	CcSEcCtD
Losartan—Malaise—Methotrexate—colon cancer	0.000146	0.00136	CcSEcCtD
Losartan—Vertigo—Methotrexate—colon cancer	0.000146	0.00135	CcSEcCtD
Losartan—Gastrointestinal pain—Capecitabine—colon cancer	0.000145	0.00135	CcSEcCtD
Losartan—Leukopenia—Methotrexate—colon cancer	0.000145	0.00135	CcSEcCtD
Losartan—Cough—Methotrexate—colon cancer	0.000141	0.00131	CcSEcCtD
Losartan—Urticaria—Capecitabine—colon cancer	0.000141	0.00131	CcSEcCtD
Losartan—Abdominal pain—Capecitabine—colon cancer	0.00014	0.00131	CcSEcCtD
Losartan—Body temperature increased—Capecitabine—colon cancer	0.00014	0.00131	CcSEcCtD
Losartan—Myalgia—Methotrexate—colon cancer	0.000138	0.00128	CcSEcCtD
Losartan—Chest pain—Methotrexate—colon cancer	0.000138	0.00128	CcSEcCtD
Losartan—Arthralgia—Methotrexate—colon cancer	0.000138	0.00128	CcSEcCtD
Losartan—Discomfort—Methotrexate—colon cancer	0.000136	0.00127	CcSEcCtD
Losartan—Confusional state—Methotrexate—colon cancer	0.000133	0.00124	CcSEcCtD
Losartan—Anaphylactic shock—Methotrexate—colon cancer	0.000132	0.00123	CcSEcCtD
Losartan—Infection—Methotrexate—colon cancer	0.000131	0.00122	CcSEcCtD
Losartan—Hypersensitivity—Capecitabine—colon cancer	0.000131	0.00122	CcSEcCtD
Losartan—Nervous system disorder—Methotrexate—colon cancer	0.00013	0.00121	CcSEcCtD
Losartan—Thrombocytopenia—Methotrexate—colon cancer	0.00013	0.0012	CcSEcCtD
Losartan—Hyperhidrosis—Methotrexate—colon cancer	0.000128	0.00119	CcSEcCtD
Losartan—Asthenia—Capecitabine—colon cancer	0.000128	0.00119	CcSEcCtD
Losartan—Anorexia—Methotrexate—colon cancer	0.000126	0.00117	CcSEcCtD
Losartan—Pruritus—Capecitabine—colon cancer	0.000126	0.00117	CcSEcCtD
Losartan—Hypotension—Methotrexate—colon cancer	0.000124	0.00115	CcSEcCtD
Losartan—Diarrhoea—Capecitabine—colon cancer	0.000122	0.00113	CcSEcCtD
Losartan—ABCB1—lymph node—colon cancer	0.000121	0.00136	CbGeAlD
Losartan—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000121	0.00112	CcSEcCtD
Losartan—Insomnia—Methotrexate—colon cancer	0.00012	0.00111	CcSEcCtD
Losartan—Paraesthesia—Methotrexate—colon cancer	0.000119	0.0011	CcSEcCtD
Losartan—Dyspnoea—Methotrexate—colon cancer	0.000118	0.0011	CcSEcCtD
Losartan—Somnolence—Methotrexate—colon cancer	0.000118	0.00109	CcSEcCtD
Losartan—Dizziness—Capecitabine—colon cancer	0.000118	0.00109	CcSEcCtD
Losartan—Dyspepsia—Methotrexate—colon cancer	0.000116	0.00108	CcSEcCtD
Losartan—Decreased appetite—Methotrexate—colon cancer	0.000115	0.00107	CcSEcCtD
Losartan—Fatigue—Methotrexate—colon cancer	0.000114	0.00106	CcSEcCtD
Losartan—Pain—Methotrexate—colon cancer	0.000113	0.00105	CcSEcCtD
Losartan—Vomiting—Capecitabine—colon cancer	0.000113	0.00105	CcSEcCtD
Losartan—Rash—Capecitabine—colon cancer	0.000112	0.00104	CcSEcCtD
Losartan—Dermatitis—Capecitabine—colon cancer	0.000112	0.00104	CcSEcCtD
Losartan—Headache—Capecitabine—colon cancer	0.000111	0.00103	CcSEcCtD
Losartan—Feeling abnormal—Methotrexate—colon cancer	0.000109	0.00101	CcSEcCtD
Losartan—Gastrointestinal pain—Methotrexate—colon cancer	0.000108	0.00101	CcSEcCtD
Losartan—Nausea—Capecitabine—colon cancer	0.000106	0.000981	CcSEcCtD
Losartan—Urticaria—Methotrexate—colon cancer	0.000105	0.000977	CcSEcCtD
Losartan—Abdominal pain—Methotrexate—colon cancer	0.000105	0.000972	CcSEcCtD
Losartan—Body temperature increased—Methotrexate—colon cancer	0.000105	0.000972	CcSEcCtD
Losartan—Hypersensitivity—Methotrexate—colon cancer	9.75e-05	0.000906	CcSEcCtD
Losartan—Asthenia—Methotrexate—colon cancer	9.49e-05	0.000882	CcSEcCtD
Losartan—Pruritus—Methotrexate—colon cancer	9.36e-05	0.00087	CcSEcCtD
Losartan—Diarrhoea—Methotrexate—colon cancer	9.05e-05	0.000841	CcSEcCtD
Losartan—Dizziness—Methotrexate—colon cancer	8.75e-05	0.000813	CcSEcCtD
Losartan—Vomiting—Methotrexate—colon cancer	8.41e-05	0.000782	CcSEcCtD
Losartan—Rash—Methotrexate—colon cancer	8.34e-05	0.000775	CcSEcCtD
Losartan—Dermatitis—Methotrexate—colon cancer	8.33e-05	0.000775	CcSEcCtD
Losartan—Headache—Methotrexate—colon cancer	8.29e-05	0.00077	CcSEcCtD
Losartan—Nausea—Methotrexate—colon cancer	7.86e-05	0.00073	CcSEcCtD
Losartan—SLCO1B1—Metabolism—ODC1—colon cancer	5.38e-05	0.0013	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CHST5—colon cancer	5.38e-05	0.0013	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	5.22e-05	0.00126	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CA7—colon cancer	5.1e-05	0.00123	CbGpPWpGaD
Losartan—ALB—Metabolism—CA7—colon cancer	5.07e-05	0.00123	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—colon cancer	5.05e-05	0.00122	CbGpPWpGaD
Losartan—UGT2B7—NRF2 pathway—TGFB1—colon cancer	5.04e-05	0.00122	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—PTGS2—colon cancer	5e-05	0.00121	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.9e-05	0.00118	CbGpPWpGaD
Losartan—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	4.89e-05	0.00118	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	4.6e-05	0.00111	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	4.56e-05	0.0011	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CA7—colon cancer	4.55e-05	0.0011	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	4.52e-05	0.00109	CbGpPWpGaD
Losartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	4.51e-05	0.00109	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—PIK3CA—colon cancer	4.47e-05	0.00108	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CA7—colon cancer	4.45e-05	0.00107	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	4.44e-05	0.00107	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	4.35e-05	0.00105	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	4.34e-05	0.00105	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	4.34e-05	0.00105	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	4.22e-05	0.00102	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	4.22e-05	0.00102	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—EP300—colon cancer	4.16e-05	0.001	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CA7—colon cancer	4.15e-05	0.001	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	4.11e-05	0.000994	CbGpPWpGaD
Losartan—UGT1A1—NRF2 pathway—TGFB1—colon cancer	4.09e-05	0.000989	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	4.08e-05	0.000985	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	4.06e-05	0.000982	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	3.99e-05	0.000965	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—CASP3—colon cancer	3.94e-05	0.000952	CbGpPWpGaD
Losartan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	3.89e-05	0.000939	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	3.86e-05	0.000933	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	3.78e-05	0.000914	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—VEGFA—colon cancer	3.78e-05	0.000913	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	3.78e-05	0.000912	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.76e-05	0.000908	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	3.7e-05	0.000894	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	3.7e-05	0.000894	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	3.7e-05	0.000893	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.62e-05	0.000875	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	3.6e-05	0.000869	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CHST5—colon cancer	3.57e-05	0.000862	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ODC1—colon cancer	3.57e-05	0.000862	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CA7—colon cancer	3.55e-05	0.000857	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	3.5e-05	0.000845	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—TGFB1—colon cancer	3.47e-05	0.000838	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—CTNNB1—colon cancer	3.45e-05	0.000834	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—VEGFA—colon cancer	3.34e-05	0.000808	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	3.34e-05	0.000806	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TP53—colon cancer	3.33e-05	0.000804	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.31e-05	0.000799	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	3.3e-05	0.000798	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CHST5—colon cancer	3.09e-05	0.000747	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ODC1—colon cancer	3.09e-05	0.000747	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—PIK3CA—colon cancer	3.07e-05	0.000743	CbGpPWpGaD
Losartan—ALB—Metabolism—ODC1—colon cancer	3.07e-05	0.000743	CbGpPWpGaD
Losartan—ALB—Metabolism—CHST5—colon cancer	3.07e-05	0.000743	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TGFB1—colon cancer	3.07e-05	0.000741	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.04e-05	0.000733	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	2.97e-05	0.000718	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ODC1—colon cancer	2.76e-05	0.000667	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CHST5—colon cancer	2.76e-05	0.000667	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.76e-05	0.000666	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CA7—colon cancer	2.74e-05	0.000662	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ODC1—colon cancer	2.69e-05	0.000651	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CHST5—colon cancer	2.69e-05	0.000651	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.6e-05	0.000628	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CHST5—colon cancer	2.52e-05	0.000608	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ODC1—colon cancer	2.52e-05	0.000608	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—AKT1—colon cancer	2.51e-05	0.000607	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.46e-05	0.000595	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ABCB1—colon cancer	2.25e-05	0.000542	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.22e-05	0.000537	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—TYMS—colon cancer	2.21e-05	0.000533	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.16e-05	0.000522	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CHST5—colon cancer	2.15e-05	0.000519	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ODC1—colon cancer	2.15e-05	0.000519	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ABCB1—colon cancer	2.12e-05	0.000511	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.09e-05	0.000506	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—TYMS—colon cancer	2.08e-05	0.000502	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.94e-05	0.00047	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ABCB1—colon cancer	1.91e-05	0.000461	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.89e-05	0.000457	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—TYMS—colon cancer	1.88e-05	0.000453	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.87e-05	0.000453	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.83e-05	0.000442	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.75e-05	0.000422	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.74e-05	0.000421	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	1.73e-05	0.000419	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	1.72e-05	0.000416	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.69e-05	0.000409	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.68e-05	0.000405	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CHST5—colon cancer	1.66e-05	0.000401	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ODC1—colon cancer	1.66e-05	0.000401	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.65e-05	0.000399	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.6e-05	0.000386	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—FGFR3—colon cancer	1.59e-05	0.000385	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PPARG—colon cancer	1.56e-05	0.000377	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ABCB1—colon cancer	1.55e-05	0.000375	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.54e-05	0.000372	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—TYMS—colon cancer	1.52e-05	0.000368	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.52e-05	0.000367	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.51e-05	0.000366	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.48e-05	0.000359	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PPARG—colon cancer	1.47e-05	0.000356	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—APC—colon cancer	1.46e-05	0.000353	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—NRAS—colon cancer	1.46e-05	0.000353	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.45e-05	0.000351	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ABCB1—colon cancer	1.42e-05	0.000343	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.4e-05	0.000339	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—TYMS—colon cancer	1.4e-05	0.000337	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—BRAF—colon cancer	1.37e-05	0.000332	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—EGFR—colon cancer	1.33e-05	0.000322	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PPARG—colon cancer	1.33e-05	0.000321	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	1.31e-05	0.000316	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.29e-05	0.000311	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.28e-05	0.000308	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—PIK3CA—colon cancer	1.27e-05	0.000307	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.27e-05	0.000307	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—KRAS—colon cancer	1.26e-05	0.000304	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.25e-05	0.000301	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTGS2—colon cancer	1.23e-05	0.000297	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTGS2—colon cancer	1.16e-05	0.00028	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PIK3CA—colon cancer	1.16e-05	0.000279	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.14e-05	0.000275	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PPARG—colon cancer	1.08e-05	0.000261	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.07e-05	0.00026	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRAS—colon cancer	1.07e-05	0.000258	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	1.07e-05	0.000258	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.05e-05	0.000254	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—colon cancer	1.04e-05	0.000252	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AKT1—colon cancer	1.04e-05	0.000251	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.04e-05	0.000251	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CASP3—colon cancer	1.03e-05	0.000249	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—EP300—colon cancer	1.02e-05	0.000247	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1e-05	0.000243	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCND1—colon cancer	1e-05	0.000242	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.98e-06	0.000241	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CTNNB1—colon cancer	9.93e-06	0.00024	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PPARG—colon cancer	9.89e-06	0.000239	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1A—colon cancer	9.7e-06	0.000234	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—EP300—colon cancer	9.63e-06	0.000233	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—colon cancer	9.44e-06	0.000228	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ABCB1—colon cancer	9.43e-06	0.000228	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TYMS—colon cancer	9.26e-06	0.000224	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EP300—colon cancer	9.23e-06	0.000223	CbGpPWpGaD
Losartan—ALB—Hemostasis—EP300—colon cancer	9.12e-06	0.00022	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SRC—colon cancer	8.98e-06	0.000217	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.96e-06	0.000216	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.88e-06	0.000214	CbGpPWpGaD
Losartan—ALB—Hemostasis—SRC—colon cancer	8.87e-06	0.000214	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—colon cancer	8.74e-06	0.000211	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—EP300—colon cancer	8.69e-06	0.00021	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—colon cancer	8.64e-06	0.000209	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NRAS—colon cancer	8.63e-06	0.000209	CbGpPWpGaD
Losartan—ALB—Hemostasis—NRAS—colon cancer	8.53e-06	0.000206	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—colon cancer	8.49e-06	0.000205	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.35e-06	0.000202	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.3e-06	0.000201	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.17e-06	0.000197	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCB1—colon cancer	8.17e-06	0.000197	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCB1—colon cancer	8.12e-06	0.000196	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—colon cancer	8.04e-06	0.000194	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFB1—colon cancer	8.02e-06	0.000194	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TYMS—colon cancer	8.02e-06	0.000194	CbGpPWpGaD
Losartan—ALB—Metabolism—TYMS—colon cancer	7.98e-06	0.000193	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB1—colon cancer	7.93e-06	0.000192	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EGFR—colon cancer	7.87e-06	0.00019	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—colon cancer	7.78e-06	0.000188	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—colon cancer	7.56e-06	0.000183	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.45e-06	0.00018	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—colon cancer	7.43e-06	0.00018	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—colon cancer	7.34e-06	0.000177	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCB1—colon cancer	7.29e-06	0.000176	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TYMS—colon cancer	7.16e-06	0.000173	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—colon cancer	7.12e-06	0.000172	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—EP300—colon cancer	7.06e-06	0.000171	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TYMS—colon cancer	6.99e-06	0.000169	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.98e-06	0.000169	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—colon cancer	6.83e-06	0.000165	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.8e-06	0.000164	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—colon cancer	6.75e-06	0.000163	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCB1—colon cancer	6.65e-06	0.000161	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—colon cancer	6.6e-06	0.00016	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARG—colon cancer	6.56e-06	0.000159	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TYMS—colon cancer	6.53e-06	0.000158	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—colon cancer	6.53e-06	0.000158	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—EP300—colon cancer	6.47e-06	0.000156	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—colon cancer	6.43e-06	0.000155	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—colon cancer	6.32e-06	0.000153	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—colon cancer	6.24e-06	0.000151	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.18e-06	0.000149	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—colon cancer	6.18e-06	0.000149	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.14e-06	0.000148	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—colon cancer	5.82e-06	0.000141	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.81e-06	0.00014	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARG—colon cancer	5.68e-06	0.000137	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCB1—colon cancer	5.68e-06	0.000137	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARG—colon cancer	5.65e-06	0.000137	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TYMS—colon cancer	5.58e-06	0.000135	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—colon cancer	5.58e-06	0.000135	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.51e-06	0.000133	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—colon cancer	5.51e-06	0.000133	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—colon cancer	5.25e-06	0.000127	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—colon cancer	5.22e-06	0.000126	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—colon cancer	5.16e-06	0.000125	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARG—colon cancer	5.07e-06	0.000123	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.03e-06	0.000121	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARG—colon cancer	4.95e-06	0.00012	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—colon cancer	4.79e-06	0.000116	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARG—colon cancer	4.63e-06	0.000112	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—colon cancer	4.47e-06	0.000108	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—colon cancer	4.45e-06	0.000107	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCB1—colon cancer	4.38e-06	0.000106	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TYMS—colon cancer	4.31e-06	0.000104	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.3e-06	0.000104	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—EP300—colon cancer	4.29e-06	0.000104	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—colon cancer	4.27e-06	0.000103	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—colon cancer	3.99e-06	9.64e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARG—colon cancer	3.95e-06	9.55e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—colon cancer	3.91e-06	9.45e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—colon cancer	3.9e-06	9.41e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—EP300—colon cancer	3.72e-06	8.98e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—EP300—colon cancer	3.7e-06	8.93e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—colon cancer	3.64e-06	8.79e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—EP300—colon cancer	3.32e-06	8.02e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—EP300—colon cancer	3.24e-06	7.83e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—colon cancer	3.18e-06	7.67e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—colon cancer	3.11e-06	7.51e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARG—colon cancer	3.05e-06	7.37e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—EP300—colon cancer	3.03e-06	7.31e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—colon cancer	2.75e-06	6.65e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—colon cancer	2.74e-06	6.61e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—colon cancer	2.59e-06	6.27e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—EP300—colon cancer	2.59e-06	6.25e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—colon cancer	2.46e-06	5.93e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—colon cancer	2.4e-06	5.8e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—colon cancer	2.4e-06	5.79e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—colon cancer	2.25e-06	5.43e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—colon cancer	2.24e-06	5.41e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—colon cancer	2.23e-06	5.4e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—colon cancer	2.01e-06	4.85e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—EP300—colon cancer	2e-06	4.82e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—colon cancer	1.96e-06	4.73e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—colon cancer	1.91e-06	4.62e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—colon cancer	1.83e-06	4.42e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—colon cancer	1.56e-06	3.78e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—colon cancer	1.48e-06	3.57e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—colon cancer	1.21e-06	2.91e-05	CbGpPWpGaD
